Bioventus Reports Q3 Adjusted EBITDA of $28.4 Million
Bioventus reported Q3 sales of $142.4 million, versus an IBES estimate of $149.5 million.
Story updates
09:08:42 PM UTC
SquawkNews
Bioventus Reports Third Quarter Financial Results Q3 reported revenue of $142.4 million increased 3%
09:08:50 PM UTC
SquawkNews
Bioventus reported Q3 2026 revenue of $142.4M, up 3%; net income was $6.0M versus $3.2M a year earlier. Adjusted EBITDA rose 7% to $28.4M, and the company said its strategic-alternatives review continues.Material DetailsContext by AI AnalystThis is a quarterly operating update amid the company's on…
09:31:47 PM UTC
SquawkNews
Bioventus reported third-quarter 2026 revenue of $142.44 million, up 2.7% from the prior-year quarter. Net income attributable to Bioventus Inc. was $5.99 million, compared with $3.16 million, while diluted EPS rose to $0.08 from $0.05.Financial Highlights¹ Reported as “Net sales”. ² Reported as “N…